Ambulatory Infusion Centers provide outpatient infusion therapy services for various chronic diseases such as cancer, multiple sclerosis, congestive heart failure, Crohn’s disease and rheumatoid arthritis at affordable prices. These centers offer comfortable and convenient setting for patients requiring long term intravenous medications and therapies. They are staffed with registered nurses, pharmacists and medical practitioners to provide safe, effective and quality care to patients. The centers help support home infusion programs by providing alternative setting for patients unable to receive treatments at home.
Market key trends:
The growth in prevalence of chronic diseases requiring intravenous treatments is driving the demand for ambulatory infusion centers globally. There is an increase in preference for outpatient settings over inpatient hospital stays for cost effectiveness as well as convenience. Rising healthcare costs have led to a shift towards affordable alternatives like ambulatory infusion centers. Growing geriatric population base susceptible to various chronic illnesses also contributes to market growth. Regulatory frameworks supporting reimbursements for outpatient infusion therapies boost the development of ambulatory infusion centers.
The global Ambulatory Infusion Center Market Size is estimated to be valued at US$ 60883.85 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Porter’s Analysis
Threat of new entrants: Low capital requirements and lack of differentiation between existing competitors make the threat of new entrants moderate. However, established networks of physicians and patients and economies of scale of existing players pose barriers.
Bargaining power of buyers: Individual consumers have low bargaining power due to lack of health insurance but group health insurers and government agencies have significant power to negotiate on price and services.
Bargaining power of suppliers: Physicians and pharmaceutical suppliers have moderate bargaining power due to dependence of infusion centers on their services and limited number of suppliers.
Threat of new substitutes: Alternate routes of administration such as self-injectables and oral drugs pose threat but infusion therapy offers convenience and accuracy which limits substitution.
Competitive rivalry: Presence of many regional and local players intensifies competition. Differentiation limited to location, quality and service adds to rivalry.
Key Takeaways
The global Ambulatory Infusion Center Market is expected to witness high growth, exhibiting CAGR of 6.7% over the forecast period, due to increasing prevalence of chronic diseases requiring infusion therapy and patient preference for outpatient setting over hospitals.
Regional analysis: North America dominated the market owing to high acceptance of ambulatory care and presence of leading players. Asia Pacific is expected to demonstrate fastest growth owing to improving healthcare infrastructure and increasing medical tourism.
Key players operating in the Ambulatory Infusion Center Market are Option Care Health, PharmaScript, Cleveland Clinic, Stoughton Health, Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI Health, PharMerica, Beacon Health System, Inc., Arnot Health, Inc., IVX Health and Precision Healthcare. Key players are focused on expansion in emerging regions through partnerships
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it